Ep. 218 - Drew Taylor of Acorn | Live from AIS 2026

What if the future of regenerative medicine starts with a few strands of your own hair? Live from AIS 2026, Dr. Grant Stevens sits down with Acorn CEO Drew Taylor to discuss the company’s progress in developing personalized, autologous exosome-based therapies derived from a patient’s own cells. Drew explains how Acorn is expanding from topical applications into injectable studies for aesthetic and hair restoration treatments, while also exploring future opportunities in areas ranging from s...